Vaccines: Subunit

Stefan Ståhl, Royal Institute of Technology, Stockholm, Sweden
Sissela Liljeqvist, Royal Institute of Technology, Stockholm, Sweden

Published online: April 2001

DOI: 10.1038/npg.els.0000490

Subunit vaccines, both purified native components of pathogens and vaccines developed and produced by recombinant techniques, are now dominating in the strive for an ideal vaccine. Subunit vaccines are highly attractive alternatives to the classical vaccines consisting of live attenuated or killed whole bacteria or viruses.

Keywords: vaccine development; recombinant; protein vaccine; surface display; live bacteria; viral vector; DNA vaccine; RNA vaccine

 References
    Ahman H, Kayhty H, Tamminen P et al. (1996) Pentavalent pneumococcal oligosaccharide conjugate vaccine PnCRM is well tolerated and able to induce an antibody response in infants. Pediatric Infectious Disease Journal 15: 134–139.
    Cano F, Plotnicky-Gilquin H, Nguyen TN et al. (2000) Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides. Vaccine 18: 2743–2752.
    Del Giudice G and Rappuoli R (1999) Genetically derived toxoids for use as vaccines and adjuvants. Vaccine 17(supplement 2): S44–S52.
    Donnelly JJ, Ulmer JB, Shiver JW and Liu MA (1997) DNA vaccines. Annual Review of Immunology 15: 617–648.
    Hannig G and Makrides SC (1998) Strategies for optimizing heterologous protein expression in Escherichia coli. Trends in Biotechnology 16: 54–60.
    Johnston SA and Barry MA (1997) Genetic to genomic vaccination. Vaccine 15: 808–810.
    Krieg AM, Yi AK, Matson S et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546–549.
    Liljeqvist S and Ståhl S (1999) Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. Journal of Biotechnology 73: 1–33.
    Mazmanian SK, Liu G, Ton-That H and Schneewind O (1999) Staphylococcus aureus sortase, an enzyme that anchors proteins to the cell wall. Science 285: 760–763.
    Nygren PÅ and Uhlén M (1997) Scaffolds for engineering novel binding sites in proteins. Current Opinion in Structural Biology 7: 463–469.
    Paoletti E (1996) Applications of pox virus vectors to vaccination: an update. Proceedings of the National Academy of Sciences of the USA 93: 11349–11353.
    Patarroyo ME, Amador R, Clavijo P et al. (1988) A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332: 158–161.
    Smerdou C and Liljeström P (2000) Alphavirus vectors: from protein production to gene therapy. Gene therapy and Regulation 1: 33–64.
    Ståhl S and Uhlén M (1997) Bacterial surface display: trends and progress. Trends in Biotechnology 15: 185–192.
    Tacket CO, Mason HS, Losonsky G et al. (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Medicine 4: 607–609.
    Ulmer JB, Donnelly JJ, Parker SE et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
    Valenzuela P, Medina A, Rutter WJ, Ammerer G and Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347–350.
 Further Reading
    Holmgren J, Lycke N and Czerkinsky C (1993) Cholera toxin and cholera toxin B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11: 1179–1184.
    McGhee JR, Mestecky J, Dertzbaugh MT et al. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75–88.
    Paoletti E (1996) Applications of pox virus vectors to vaccination: an update. Proceedings of the National Academy of Sciences of the USA 93: 11349–11353.
    Plotkin SA (1993) Vaccination in the 21st century. Journal of Infectious Diseases 168: 29–37.
    book Ståhl S, Samuelson S, Hansson M et al. (1997) "Development of non-pathogenic staphylococci as vaccine delivery vehicles". In: Wells J and Pozzi G (eds) Recombinant Gram-positive Bacteria as Vaccine Vehicles for Mucosal Immunization, pp. 61–81. New York: RG Landes Biomedical.
    Vaccine supplement (1998) Nature Medicine 4(5): 474–531.

Related Sub-Topics:

Vaccines | Viral Vaccines | Medical Microbiology
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Vaccines: Subunit
 
How to Cite close
Ståhl, Stefan, and Liljeqvist, Sissela(Apr 2001) Vaccines: Subunit. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0000490]